Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 3,601,100 | 3,667,700 | 3,497,400 | 3,644,300 | 3,280,400 |
Cost of Goods | 845,700 | 871,300 | 859,000 | 865,700 | 810,100 |
Gross Profit | 2,755,400 | 2,796,400 | 2,638,400 | 2,778,600 | 2,470,300 |
Operating Expenses | 1,822,600 | 1,908,800 | 1,792,600 | 1,834,301 | 1,606,800 |
Operating Income | 933,500 | 887,900 | 845,800 | 945,000 | 863,600 |
Interest Expense | 0 | 0 | 0 | 0 | 18,500 |
Other Income | 85,000 | -1,028,000 | 98,600 | -425,000 | 123,100 |
Pre-tax Income | 1,018,500 | -140,100 | 944,400 | 520,000 | 968,200 |
Income Tax | 224,100 | 111,900 | 207,800 | 522,400 | 213,000 |
Net Income Continuous | 794,400 | -252,000 | 736,600 | -2,400 | 755,200 |
Net Income | $794,400 | $-252,000 | $736,600 | $-2,400 | $755,200 |
EPS Basic Total Ops | 0.73 | -0.23 | 0.68 | -0.01 | 0.70 |
EPS Basic Continuous Ops | 0.73 | -0.23 | 0.68 | 0.00 | 0.70 |
EPS Diluted Total Ops | 0.73 | -0.23 | 0.68 | 0.00 | 0.69 |
EPS Diluted Continuous Ops | 0.73 | -0.23 | 0.68 | 0.00 | 0.69 |
EBITDA(a) | $1,117,400 | $1,046,600 | $1,004,500 | $1,081,699 | $1,026,800 |